Compare NARMADA GELATINES with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NARMADA GELATINES vs ROSSARI BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NARMADA GELATINES ROSSARI BIOTECH NARMADA GELATINES/
ROSSARI BIOTECH
 
P/E (TTM) x 13.1 78.2 16.7% View Chart
P/BV x 0.8 18.2 4.1% View Chart
Dividend Yield % 5.8 0.0 15,538.6%  

Financials

 NARMADA GELATINES   ROSSARI BIOTECH
EQUITY SHARE DATA
    NARMADA GELATINES
Mar-21
ROSSARI BIOTECH
Mar-21
NARMADA GELATINES/
ROSSARI BIOTECH
5-Yr Chart
Click to enlarge
High Rs2081,146 18.2%   
Low Rs111664 16.7%   
Sales per share (Unadj.) Rs222.9136.6 163.2%  
Earnings per share (Unadj.) Rs14.015.3 91.2%  
Cash flow per share (Unadj.) Rs16.419.7 83.3%  
Dividends per share (Unadj.) Rs10.000.50 2,000.0%  
Avg Dividend yield %6.30.1 11,339.4%  
Book value per share (Unadj.) Rs229.478.3 293.0%  
Shares outstanding (eoy) m6.0551.93 11.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.76.6 10.8%   
Avg P/E ratio x11.459.0 19.3%  
P/CF ratio (eoy) x9.745.8 21.2%  
Price / Book Value ratio x0.711.6 6.0%  
Dividend payout %71.53.3 2,193.7%   
Avg Mkt Cap Rs m96546,975 2.1%   
No. of employees `000NANA-   
Total wages/salary Rs m115420 27.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,3497,093 19.0%  
Other income Rs m5592 59.9%   
Total revenues Rs m1,4047,185 19.5%   
Gross profit Rs m761,231 6.1%  
Depreciation Rs m15228 6.5%   
Interest Rs m230 5.6%   
Profit before tax Rs m1141,064 10.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29268 11.0%   
Profit after tax Rs m85796 10.6%  
Gross profit margin %5.617.3 32.3%  
Effective tax rate %25.825.2 102.7%   
Net profit margin %6.311.2 55.9%  
BALANCE SHEET DATA
Current assets Rs m7383,814 19.3%   
Current liabilities Rs m1891,769 10.7%   
Net working cap to sales %40.728.8 141.0%  
Current ratio x3.92.2 180.6%  
Inventory Days Days16742 397.0%  
Debtors Days Days48474 652.3%  
Net fixed assets Rs m9112,633 34.6%   
Share capital Rs m61104 58.3%   
"Free" reserves Rs m1,3273,963 33.5%   
Net worth Rs m1,3884,067 34.1%   
Long term debt Rs m00-   
Total assets Rs m1,6496,448 25.6%  
Interest coverage x69.336.6 189.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.1 74.4%   
Return on assets %5.212.8 40.8%  
Return on equity %6.119.6 31.1%  
Return on capital %8.326.9 31.0%  
Exports to sales %1.09.1 11.3%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs m14645 2.1%   
Imports (cif) Rs mNA1,336 0.0%   
Fx inflow Rs m14645 2.1%   
Fx outflow Rs m11,336 0.1%   
Net fx Rs m13-691 -1.9%   
CASH FLOW
From Operations Rs m31478 6.6%  
From Investments Rs m59-372 -15.8%  
From Financial Activity Rs m-67-246 27.1%  
Net Cashflow Rs m23-140 -16.8%  

Share Holding

Indian Promoters % 0.0 68.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 0.0 21.3 0.0%  
FIIs % 0.0 8.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 31.4 79.5%  
Shareholders   3,118 65,831 4.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NARMADA GELATINES With:   PIDILITE INDUSTRIES  GUJARAT ALKALIES  VINATI ORGANICS  AARTI INDUSTRIES  TATA CHEMICALS  



Today's Market

4 Reasons Why Sensex Surged 1,016 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

ROSSARI BIOTECH 2020-21 Annual Report Analysis (Annual Result Update)

Oct 25, 2021 | Updated on Oct 25, 2021

Here's an analysis of the annual report of ROSSARI BIOTECH for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ROSSARI BIOTECH. Also includes updates on the valuation of ROSSARI BIOTECH.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

India's New Drone Scheme: Watch Out for these Stocks (Views On News)

Oct 1, 2021

New drone rules and the PLI scheme is a huge confidence booster for startups and MSMEs. It will open new opportunities for drone companies.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NARMADA GELATINES SHARE PRICE


Dec 8, 2021 (Close)

TRACK NARMADA GELATINES

  • Track your investment in NARMADA GELATINES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NARMADA GELATINES

NARMADA GELATINES - VIVID GLOBAL INDUSTRIES COMPARISON

COMPARE NARMADA GELATINES WITH

MARKET STATS